December 2023
1. SIMMONS HC, Watanabe A, Oguin Iii TH, Van Itallie ES, et al
   A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
   PLoS Biol. 2023;21:e3002415.
   

   >> Share

   
   November 2023
2. KALIMUDDIN S, Ooi EE
   Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics.
   PLoS Biol. 2023;21:e3002351.
   

   >> Share

   
   September 2023
3. KORDAHI MC, Delaroque C, Bredeche MF, Gewirtz AT, et al
   Vaccination against microbiota motility protects mice from the detrimental impact of dietary emulsifier consumption.
   PLoS Biol. 2023;21:e3002289.
   

   >> Share

   
   March 2023
4. HERNANDEZ-GONZALEZ M, Calcraft T, Nans A, Rosenthal PB, et al
   A succession of 2 viral lattices drives vaccinia virus assembly.
   PLoS Biol. 2023;21:e3002005.
   

   >> Share

   
   September 2022
5. DAY T, Kennedy DA, Read AF, Gandon S, et al
   Pathogen evolution during vaccination campaigns.
   PLoS Biol. 2022;20:e3001804.
   

   >> Share

   
   
6. KOEKEN VACM, Qi C, Mourits VP, de Bree LCJ, et al
   Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination.
   PLoS Biol. 2022;20:e3001765.
   

   >> Share

   
   May 2022
7. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
   Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
   PLoS Biol. 2022;20:e3001609.
   

   >> Share

   
   
8. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
   No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
   PLoS Biol. 2022;20:e3001506.
   

   >> Share

   
   
9. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
   Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
   PLoS Biol. 2022;20:e3001643.
   

   >> Share

   
   April 2022
10. NUISMER SL
    One step closer to a transmissible vaccine for rabies virus.
    PLoS Biol. 2022;20:e3001607.
    

    >> Share

    
    
11. GRIFFITHS ME, Broos A, Bergner LM, Meza DK, et al
    Longitudinal deep sequencing informs vector selection and future deployment strategies for transmissible vaccines.
    PLoS Biol. 2022;20:e3001580.
    

    >> Share

    
    December 2021
12. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
    Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
    PLoS Biol. 2021;19:e3001384.
    

    >> Share

    
    November 2021
13. KESSIE DK, Rudel T
    Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
    PLoS Biol. 2021;19:e3001462.
    

    >> Share

    
    
14. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share